Geschreven door studenten die geslaagd zijn Direct beschikbaar na je betaling Online lezen of als PDF Verkeerd document? Gratis ruilen 4,6 TrustPilot
logo-home
Tentamen (uitwerkingen)

NUR 254 Exam 2 Actual Exam 2026/2027 | Cardiovascular Respiratory Endocrine GI Renal with Detailed Rationales | Pass Guaranteed – A+ Graded

Beoordeling
-
Verkocht
-
Pagina's
27
Cijfer
A+
Geüpload op
22-05-2026
Geschreven in
2025/2026

NUR 254 Exam 2 Actual Exam 2026/2027 – Real-Style Exam Questions | 100% Correct Answers | Cardiovascular Disorders | Respiratory Conditions | Hematologic & Endocrine | GI & Renal Systems | Detailed Rationales | Graded A+ Verified – Pass Guaranteed – Instant Download

Meer zien Lees minder
Instelling
NUR 254
Vak
NUR 254

Voorbeeld van de inhoud

NUR 254 Exam 2 Actual Exam 2026/2027 |
Cardiovascular Respiratory Endocrine GI Renal with
Detailed Rationales | Pass Guaranteed – A+ Graded



CARDIOVASCULAR DISORDERS (12 Questions)

Q1: A 62-year-old Black male with hypertension (BP 148/88 mmHg on three visits) has
no other comorbidities. His 10-year ASCVD risk is 12%. According to ACC/AHA 2017
guidelines, which initial antihypertensive medication is MOST appropriate?

A. Lisinopril

B. Amlodipine [CORRECT]

C. Metoprolol

D. Hydrochlorothiazide

Rationale: Correct because ACC/AHA guidelines recommend CCB (amlodipine) or
thiazide diuretic as first-line for Black patients with hypertension due to lower renin
profile; ACEi/ARB are less effective as monotherapy in Black patients; beta-blockers are
not first-line for uncomplicated hypertension.



Q2: A 58-year-old female with type 2 diabetes and CKD stage 3b (eGFR 38 mL/min,
UACR 450 mg/g) has BP 142/90 mmHg on lifestyle modifications. Which
antihypertensive regimen is MOST appropriate to initiate?

A. Amlodipine monotherapy

,B. Lisinopril [CORRECT]

C. Chlorthalidone monotherapy

D. Metoprolol succinate

Rationale: Correct because ACE inhibitors (or ARBs) are first-line in diabetes with
albuminuria (>300 mg/g) due to renal protective effects and reduction of proteinuria;
they slow progression of CKD; diuretics and CCB are add-on agents but do not provide
the same renoprotection.



Q3: A 55-year-old male with hypertension has been adherent to lisinopril, amlodipine,
and chlorthalidone for 6 months. Home BP readings remain 158/96 mmHg. Labs show
potassium 3.2 mEq/L. Which is the BEST next step?

A. Switch lisinopril to losartan

B. Add metoprolol succinate

C. Add spironolactone [CORRECT]

D. Switch to hydralazine

Rationale: Correct because this is resistant hypertension (uncontrolled on 3 agents
including a diuretic); spironolactone is the most effective fourth-line agent for resistant
hypertension and will also correct hypokalemia; switching within the same class or
adding beta-blocker provides less BP reduction.



Q4: A 68-year-old male presents with BP 220/130 mmHg, headache, confusion, and
acute pulmonary edema. Which management approach is MOST appropriate for the
FIRST hour?

, A. Lower BP to <140/90 within 30 minutes

B. Reduce MAP by no more than 25% using IV nicardipine [CORRECT]

C. Administer sublingual nifedipine for rapid reduction

D. Begin oral lisinopril and discharge when stable

Rationale: Correct because hypertensive emergency requires controlled reduction; IV
nicardipine is appropriate; MAP should not drop >25% in the first hour to prevent
cerebral hypoperfusion; sublingual nifedipine causes precipitous drops and is
contraindicated; oral agents are inappropriate for emergency.



Q5: A 64-year-old male reports chest pressure with walking 2 blocks that resolves with
rest. Troponin is negative. ECG shows no ST changes. Which diagnosis is MOST likely?

A. STEMI

B. NSTEMI

C. Unstable angina

D. Stable angina [CORRECT]

Rationale: Correct because symptoms are predictable with exertion, relieved by rest, and
troponin is negative; this defines stable angina; unstable angina would be crescendo or
at rest; NSTEMI and STEMI involve elevated troponins.



Q6: A 59-year-old male has crushing substernal chest pain for 2 hours. ECG shows ST
elevation in leads II, III, and aVF. Which intervention has the STRONGEST mortality
benefit?

Geschreven voor

Instelling
NUR 254
Vak
NUR 254

Documentinformatie

Geüpload op
22 mei 2026
Aantal pagina's
27
Geschreven in
2025/2026
Type
Tentamen (uitwerkingen)
Bevat
Vragen en antwoorden

Onderwerpen

€12,36
Krijg toegang tot het volledige document:

Verkeerd document? Gratis ruilen Binnen 14 dagen na aankoop en voor het downloaden kun je een ander document kiezen. Je kunt het bedrag gewoon opnieuw besteden.
Geschreven door studenten die geslaagd zijn
Direct beschikbaar na je betaling
Online lezen of als PDF

Maak kennis met de verkoper
Seller avatar
CLEARVISION

Maak kennis met de verkoper

Seller avatar
CLEARVISION Rasmussen College
Volgen Je moet ingelogd zijn om studenten of vakken te kunnen volgen
Verkocht
-
Lid sinds
3 weken
Aantal volgers
0
Documenten
44
Laatst verkocht
-

0,0

0 beoordelingen

5
0
4
0
3
0
2
0
1
0

Recent door jou bekeken

Waarom studenten kiezen voor Stuvia

Gemaakt door medestudenten, geverifieerd door reviews

Kwaliteit die je kunt vertrouwen: geschreven door studenten die slaagden en beoordeeld door anderen die dit document gebruikten.

Niet tevreden? Kies een ander document

Geen zorgen! Je kunt voor hetzelfde geld direct een ander document kiezen dat beter past bij wat je zoekt.

Betaal zoals je wilt, start meteen met leren

Geen abonnement, geen verplichtingen. Betaal zoals je gewend bent via iDeal of creditcard en download je PDF-document meteen.

Student with book image

“Gekocht, gedownload en geslaagd. Zo makkelijk kan het dus zijn.”

Alisha Student

Bezig met je bronvermelding?

Maak nauwkeurige citaten in APA, MLA en Harvard met onze gratis bronnengenerator.

Bezig met je bronvermelding?

Veelgestelde vragen